甲状腺癌中的BRAF V600E:应对预后不确定性和治疗机会
Garcilaso Riesco-Eizaguirre1,2
1Department of Endocrinology and Nutrition, Hospital Universitario de Móstoles, Madrid, Spain.
European thyroid journal
|December 10, 2025
概括
在甲状腺癌中,BRAF V600E突变具有复杂的作用. 虽然它可以表明更糟糕的结果和对放射性 (RAI) 的耐药性,但它的预后价值仍在争论中,有针对性的疗法显示出希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 布拉夫V600E是乳头甲状腺癌中常见的致癌驱动因素,激活了MAPK通路.
- 这种突变与侵略性特征有关,但其独立的预后价值仍在争论中.
- BRAF V600E影响放射性 (RAI) 的折射性,尽管瘤异质性会影响反应.
研究的目的:
- 审查BRAF V600E在甲状腺癌中的作用.
- 讨论它的预后价值,分子异质性和治疗潜力.
- 探索BRAF V600E状态如何告知治疗策略.
主要方法:
- 在甲状腺癌中对BRAF V600E的研究的文献综述.
- 对预后意义,分子特征和治疗反应的数据分析.
- 检查BRAF向治疗的临床试验结果.
主要成果:
- BRAF V600E与不良结果有关,但其预后效用有争议.
- 分子异质性,包括转录和基因组差异,影响治疗反应.
- BRAF和MEK抑制剂在晚期甲状腺癌中表现出有效性,FDA批准某些类型.
结论:
- BRAF V600E状态至关重要,但必须与个性化治疗的分子异质性一起考虑.
- 针对性疗法为晚期BRAF V600E突变甲状腺癌提供了新的希望.
- 通过MAPK抑制剂恢复RAI热情是被选中的患者的一个有希望的策略.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
The Thyroid Gland
6.5K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.5K
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


